ACTR-89. KARNOFSKY PERFORMANCE STATUS AND STEROID USE IN PHASE II TRIAL OF BEVACIZUMAB AND TEMOZOLOMIDE FOR UPFRONT TREATMENT OF ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
- Resource Type
- Source
- Subject
Oncology Cancer Research medicine.medical_specialty Temozolomide Bevacizumab Karnofsky Performance Status business.industry Newly diagnosed medicine.disease Abstracts Text mining Tumor progression Steroid use Internal medicine Medicine Neurology (clinical) business medicine.drug Glioblastoma - Language
- English